Gore Excluder髂支内假体以髂内动脉分支作为远端锚定区的 outcomes
本研究评估Gore Excluder髂支内假体(IBE)以髂内动脉(IIA)分支作为远端锚定区的结局,纳入74例患者(85条血管),比较主体锚定与分支锚定的早期和晚期结果。结果显示两组技术成功率97%,1年生存率94%,主要和次要通畅率、分支不稳定性及臀肌跛行发生率均无显著差异。结论认为该技术中期安全有效,可扩展适应症,但需长期评估。
要点
- IBE远端锚定于IIA分支与主体相比,早期技术成功率和30天不良事件无显著差异。
- 1年原发和次要通畅率、分支不稳定性及新发臀肌跛行在两组间均无显著差异。
- 该技术可能将血管内修复适应症扩展至IIA主体解剖不适合的病例。
核心结论
- 使用IIA后或前分支作为Gore Excluder IBE远端锚定区在中期安全有效。
- 该技术可能扩展主动脉髂动脉瘤血管内修复的适应症至IIA主体解剖不适合的病例。
- 需要长期评估以确认该技术的有效性。
研究设计与样本
- 回顾性研究,纳入2014年1月1日至2018年12月31日74例(平均年龄74±7岁;72例男性)主动脉髂或髂总动脉瘤患者。
- 早期终点包括技术成功、30天死亡率、30天主要不良事件(MAE)和30天主要入路并发症;晚期终点包括生存率、IIA通畅率、分支不稳定性、臀肌跛行及瘤囊直径变化。
- 时间依赖结局采用Kaplan-Meier曲线和log-rank检验,估计值以95%CI呈现。
主要发现
- 总体技术成功率97%,每组各1例技术失败(p=0.43)。
- 每组各1例30天内死亡(p=0.43)。
- 主体组与分支组30天MAE发生率分别为7% vs 17%(p=0.35),主要入路并发症为9% vs 11%(p>0.99)。
- 全队列平均随访19±12个月,总体1年生存率94%(95%CI 74% to 99%)。
- 1年原发通畅率主体组98%(95%CI 88% to 99%)vs 分支组95%(95%CI 72% to 99%,p=0.72);次要通畅率98%(95%CI 88% to 99%)vs 100%(p=0.41)。
临床怎么用
- 对于IIA主体解剖不适合作为远端锚定区的主动脉髂动脉瘤患者,可考虑将IBE侧支锚定于IIA后或前分支。
- 该技术中期通畅率和分支稳定性与主体锚定相似,可作为扩展血管内修复适应症的选择。
局限性
- 样本量较小(74例患者,85条血管),可能影响统计效能。
- 随访时间较短(平均19±12个月),缺乏长期结果。
- 原文未报告随机化或盲法,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose: To evaluate the outcomes of the Gore Excluder Iliac Branch Endoprosthesis (IBE) using division branches of the internal iliac artery (IIA) as distal landing zones. Materials and Methods: Between January 1, 2014, and December 31, 2018, 74 patients (mean age 74±7 years; 72 men) treated for aortoiliac or common iliac artery aneurysms had an IBE deployed with distal landing of the side branch within the main trunk (n=60) of the internal iliac artery (IIA) vs within a division branch (n=25). Thirteen (17%) patients received bilateral IBE implantations for a total of 85 vessels evaluated. Early endpoints were technical success, 30-day mortality, 30-day major adverse events (MAEs), and 30-day major access complications. Late endpoints were survival, primary and secondary IIA patency, freedom from IIA branch instability, freedom from new-onset buttock claudication, and aneurysm sac diameter changes. Time-dependent outcomes were reported as Kaplan-Meier curves with differences assessed using the log-rank test. Estimates are presented with the 95% confidence interval (CI). Results: The overall technical success rate was 97%, with 1 technical failure per group (p=0.43). Two patients, one from each group, died within 30 days (p=0.43). No significant differences were seen in the rates of 30-day MAEs (7% vs 17%, p=0.35) or major access complications (9% vs 11%, p>0.99) for patients receiving distal landing in the main trunk vs a division branch, respectively. The mean follow-up for the entire cohort was 19±12 months. The overall 1-year survival rate was 94% (95% CI 74% to 99%). The primary and secondary patency rates at 1 year were 98% (95% CI 88% to 99%) vs 95% (95% CI 72% to 99%, p=0.72) and 98% (95% CI 88% to 99%) vs 100% (p=0.41) for the main trunk vs division branch groups, respectively. Freedom from IIA branch instability estimates were also similar at 1-year follow-up [93% (95% CI 82% to 97%) vs 90% (95% CI 66% to 97%), p=0.29], as were the freedom from new-onset buttock claudication estimates [98% (95% CI 86% to 99%) and 94% (95% CI 67% to 99%), respectively; p=0.62]. Mean sac diameter change was 5.4±5.3 mm, not significantly different between the groups (p=0.85). Conclusion: Use of the posterior or anterior division of the IIA as a distal landing zone for the Gore Excluder IBE was safe and efficacious in the midterm. This technique may permit extending indications for endovascular repair of aortoiliac aneurysms to cases with unsuitable anatomy within the IIA main trunk. Long-term assessment is needed to affirm the efficacy of this technique.
引用
- D'Oria M, Tenorio ER, Oderich GS, et al. Outcomes of the Gore Excluder Iliac Branch Endoprosthesis Using Division Branches of the Internal Iliac Artery as Distal Landing Zones. J Endovasc Ther. 2020. PMID: 32066324. doi:10.1177/1526602820905583
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。